Recent Publications

Recent publications across all six ISSDP Grey Literature Bibliography Categories are held here for one month. They will then be located in specific categories in the main Bibliography to be replaced by more recent research.

 

 

ISSDP BIBLIOGRAPHY
Harm reduction and HIV prevention need among gay men in London using GHB/GBL, crystal methamphetamine and mephedrone during sex (July 2014)
Changing trends in drug use among gay men in London have not been matched by a re-positioning of harm reduction services to meet their needs (Sigma)
 
Indicator 5: Improved outcomes for those receiving treatment for drug or alcohol dependency (July 2014)
This indicator is designed to reflect progress in these areas, and considers the links between recovery, offending and employment (Government, UK)
 
Non-medical prescribing in the management of substance misuse (July 2014)
PHE’s new document, which replaces a 2007 NTA publication, is intended for non-medical prescribers and all those with an interest in NMP including aspiring non-medical prescribers, consultants and clinical leads, service managers, NMP leads, colleagues from different professions (eg, doctors, psychologists, and social workers) and service commissioners (Public Health England)
 
EMCDDA–Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (July 2014)
In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4'-DMAR). The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4,4'-DMAR as stipulated by Article 5.1 of the Council Decision (EMCDDA)
 
National Drugs Strategy Household Surveys (July 2014)
Highlights from the 2013 survey (AIHW)
 
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations (July 2014)
Includes people who inject drugs (WHO)
 
EMCDDA–Eurojust Memorandum of understanding (July 2014)
Exchanging strategic and technical information in the areas of drug legislation and supply was among the pledges made today in a Memorandum of Understanding (MoU) signed by the EU drugs agency (EMCDDA) and the EU judicial cooperation unit (Eurojust)
 
Childhood and Adolescent Pathways to Substance Use Disorders (July 2014)
The present report focuses on how biological, behavioural and social factors during the early developmental years play a role in later-life substance abuse, as well as in concurrent mental and physical health problems (Canadian Centre on Substance Abuse)
 
Residential treatment for drug use in Europe (July 2014)
The aim of this paper is to provide a Europe-wide overview of the history and availability of residential drug treatment within wider national drug treatment systems (EMCDDA)
 
The Links between Mephedrone Use, Violence and other Harms in South Wales (July 2014)
This research, funded by Welsh Government and South Wales Police, was commissioned in response to growing concerns by police, other criminal justice professionals and a range of practitioners who work with drug users, about the negative impacts of mephedrone use upon users, their families and communities (Centre for Criminology University of South Wales)
 
Use of psychoactive substances in research: letter (July 2014)
Letter from Home Office Drugs and Alcohol Unit to Les Iversen provides feedback on a departmental scoping exercise that investigated whether controlled drug legislation is impeding the use of Schedule 1 psychoactive substances in legitimate research (Government, UK)
 
Report on the conference on the National Drugs Strategy (July 2014)
On 16 January 2014, the Department of Health hosted a half-day conference on the National Drugs Strategy for those in the government, statutory, community and voluntary sectors working in the drugs and alcohol field (Ireland)
 
EMCDDA-Europol 2013 Annual Report on the implementation of Council Decision 2005/387/JHA (July 2014)
This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2013, Joint Reports produced, risk assessments conducted and public health alerts and advisories issued
 
The Workplace as an AOD-Related Harm Prevention and Intervention Setting (July 2014)
Research has demonstrated that workplaces both contribute to and are impacted by employees' alcohol and other drug use (NCETA)
 
A drug policyfor the 21st century (July 2014)
The Obama Administration’s plan to reduce drug use and its consequences—the National Drug Control Strategy—represents a 21st century approach to drug policy (White House, USA)
 
In Search of Rights (July 2014)
Drug Users and State Responses in Latin America (CEDD)
 
All you need to know about Polish Drug routes (July 2014)
Polish drug market analysis (Drug Reporter)
 
No Time to Waste (July 2014)
Evidence-Based Treatment for Drug Dependence at the United States Veterans Administration Department of Veterans Affairs - Report (Human Rights Watch)
 
Drug misuse and dependence (July 2014)
UK guidelines on clinical management (Public Health England)
 
The 2012 ESPAD impact survey (July 2014)
The survey was a joint initiative of the Pompidou Group and ESPAD, with a contribution of the EMCDDA.
 
Young people and drugs (June 2014)
Survey requested by the Directorate-General for Justice and co-ordinated by the Directorate-General for Communication (Eurobarometer)
 
Genetic predisposition to schizophrenia associated with increased use of cannabis (June 2014)
Although directly predicting only a small amount of the variance in cannabis use, these findings suggest that part of the association between schizophrenia and cannabis is due to a shared genetic aetiology (Nature)
 
The World Drug Report (June 2014)
Provides an annual overview of the major developments in drug markets for the various drug categories, ranging from production to trafficking, including development of new routes and modalities, as well as consumption (UNODC)
 
The Alternative World Drug Report (June 2014)
The Alternative World Drug Report, launched to coincide with the publication of the UN Office on Drugs and Crime’s 2012 World Drug Report, exposes the failure of governments and the UN to assess the extraordinary costs of pursuing a global war on drugs, and calls for UN member states to meaningfully count these costs and explore all the alternatives (Count the Costs)
 
Drug use, impaired driving and traffic accidents, second edition (June 2014)
This literature review provides a comprehensive report on the relationship between drug use, impaired driving and traffic accidents. It describes methodological issues, presents the results of prevalence surveys among drivers, provides an overview of findings from major international epidemiological surveys, and gathers evidence from experimental and field studies of the relationship between drug use, driving impairment and traffic accidents (EMCDDA)
 
Return to the top of the page